Zheng Zhu
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Machine learning-assisted computation of the solubility of solid drugs in supercritical carbon dioxide.
Journal: Frontiers in chemistry
Published: May 17, 2026
Microcrystalline-Infused Peptide Hydrogel Enables Sustained Tacrolimus Delivery to Prolong Survival and Prevent Rejection in Kidney Transplantation.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: December 13, 2025
Polysialylated CD56 drives immune evasion in clear cell renal cell carcinoma via engagement of the Siglec-7 checkpoint on CD8+ T cells.
Journal: International immunopharmacology
Published: November 16, 2025
Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.
Journal: Human cell
Published: August 06, 2024
Oral Lactoferrin-Responsive Formulation Anchoring around Inflammatory Bowel Region for IBD Therapy.
Journal: Advanced healthcare materials
Published: July 24, 2024
Innovative strategies in genitourinary cancer: the role of oncolytic viruses.
Journal: Frontiers in oncology
Published: July 08, 2024
Landscape of targeted therapies for advanced urothelial carcinoma.
Journal: Exploration of targeted anti-tumor therapy
Published: December 22, 2023
Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG.5.1 and BA.2.86.
Journal: Journal of medical virology
Published: December 10, 2023
Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.
Journal: Stem cell research & therapy
Published: September 29, 2023
Small-molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual-inhibiting properties for bladder cancer treatment.
Journal: Exploration (Beijing, China)
Published: September 21, 2022
Last Updated: 09/26/2026